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Abstract 1 
 2 
Aim 3 
To estimate the cost effectiveness of intramedullary nail fixation in comparison to 4 
‘locking’ plate fixation for the treatment of extra-articular fractures of the distal tibia.  5 
 6 
Methods 7 
An economic evaluation, from the UK National Health Service (NHS) and personal 8 
social services (PSS) perspective, was conducted based on evidence from the 9 
Fixation of Distal Tibia Fractures (UK FixDT) multicentre, parallel trial. Data from 321 10 
patients were available for analysis. Costs were collected prospectively over the 12-11 
month follow-up period using trial case report forms and participant-completed 12 
questionnaires. Cost-effectiveness was reported in terms of incremental cost per 13 
quality adjusted life year (QALY) gained and net monetary-benefit. Sensitivity 14 
analyses were conducted to test robustness of the cost-effectiveness estimates. 15 
 16 
Results 17 
Mean NHS and PSS costs were significantly lower for patients treated with nail 18 
fixation over those treated with locking plate (-£970, 95% CI: -1685 to -256; P=0.05). 19 
There was a small increase in QALYs gained in the nail fixation group (0.01, 95% CI: 20 
-0.03 to 0.06; P=0.52). The probability of cost-effectiveness for nail fixation exceeded 21 
90% at cost-effectiveness thresholds as low as £15,000 per additional QALY. The 22 
cost-effectiveness results remained robust to several sensitivity analyses. 23 
 24 
Conclusions 25 
This trial-based economic evaluation suggests that nail fixation is a cost-effective 26 
alternative to locking plate fixation.  27 
  28 
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Clinical Relevance of Paper  29 
 30 
 The paper adds important evidence on the cost-effectiveness of alternative 31 
treatment options for extra-articular fractures of the distal tibia. 32 
 33 
  34 
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Introduction 35 
 36 
Optimal management of extra-articular fractures of the distal tibia remains disputed. 37 
Although plates and intramedullary (IM) nails represent two viable approaches to 38 
internal fixation of these fractures, each possesses distinct disadvantages. The bolts 39 
or screws that are inserted into the nail may break, mal-alignment of the bone may 40 
occur, and there is an increased risk of anterior knee pain [1]. Whilst tibial plating with 41 
‘locking’ plates can achieve accurate reduction, the need for greater soft tissue 42 
dissection increases the risk of infection, wound breakdown and damage to the 43 
surrounding structures [1, 2].  44 
 45 
Evidence from previous meta-analyses and systematic reviews comparing nailing 46 
versus plating treatment modalities have been inconclusive. Mao et al reviewed 1863 47 
extra-articular fractures of the distal tibia [3]. They reported that rates of deep 48 
infection, delayed union and removal of instrumentation were similar for patients 49 
undergoing nail and plate fixation, but nail fixation was associated with significantly 50 
more mal-unions. In contrast, Zelle et al found that mal-union rates were similar 51 
between the two treatment groups [4]. However,  the studies included in the meta-52 
analyses had heterogeneous study designs and the randomised controlled trials 53 
lacked methodologic rigour [3].  54 
 55 
The prolonged recovery and rehabilitation following a distal tibia fracture, along with 56 
complications associated with treatment choice, have important economic 57 
consequences. These injuries not only generate direct treatment costs but indirect 58 
costs, including income losses due to work absences. Given rapidly escalating 59 
health care costs, and the need to allocate finite health care resources more 60 
efficiently, the costs associated with nail and locking plate fixation should be 61 
considered alongside the clinical benefits. Data comparing the clinical and cost-62 
effectiveness of intramedullary nail and locking plate management of distal tibial 63 
fractures are currently limited. Available data are based on assessments of 64 
intramedullary nails alone [5], different plates for fixation alone [6], or compare nail 65 
fixation with interventions other than locking plates.  66 
 67 
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We present a prospectively-conducted health economic evaluation from a multi-68 
centre randomised controlled trial of intramedullary nail fixation versus locking plate 69 
fixation for the treatment of adult patients with a displaced fracture of the distal tibia.  70 
 71 
 72 
Patients and methods 73 
 74 
Trial background 75 
Data from the Fixation of Distal Tibia Fractures (UK FixDT) trial formed the basis of 76 
the economic evaluation [7]. Briefly, patients were eligible for the trial if: (i) they had a 77 
fracture that involved the distal tibial metaphysis; (ii) were aged 16 years or over; and 78 
(iii) the treating surgeon believed that they would benefit from internal fixation of the 79 
fracture. Participants were recruited from 28 UK Trauma Hospitals between April 80 
2013 and February 2016 and followed-up for one year. They were randomly 81 
allocated to either intramedullary nail fixation or locking-plate fixation. All surgery was 82 
performed according to the preferred technique of the operating surgeon. A sample 83 
size of 320 was required to detect, with 90% power at the 5% level, a difference of 8 84 
points in the primary clinical outcome, namely the disability rating index (DRI). Full 85 
details of the trial protocol are available in open access [1].  86 
 87 
Ethics committee approval 88 
The FixDT trial was approved by the Coventry and Warwickshire Research Ethics 89 
Committee on 06 November 2012 (REC reference: 12/WM/0340) and by the 90 
Research and Development department of each participating centre. 91 
 92 
Study Perspective and Time Horizon 93 
The primary analysis was undertaken from the perspective of the UK National Health 94 
Service (NHS) and Personal Social Services (PSS) as recommended by the 95 
National Institute of Health and Care Excellence (NICE) [8]. The time horizon for 96 
the economic evaluation followed the 12-month follow-up period of the trial, and 97 
therefore no discounting of costs and benefits was required. Under normal 98 
circumstances, uncomplicated fractures of the distal tibia would be expected to be 99 
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clinically united at 6 months and patients returned to normal activities [2, 9]. The 12-100 
month follow-up period is thus well suited to capture clinically important differences 101 
between the two procedures and in non-unions that result in revision fixations and 102 
rehospitalisation.  103 
 104 
Measurement and valuation of resource use 105 
Estimation of the costs associated with the interventions included the cost of the 106 
initial surgery and the broader health and PSS resource inputs, plus, for the 107 
purposes of a sensitivity analysis, personal costs and broader societal resource 108 
inputs. All costs were expressed in £ sterling and valued in 2014-15 prices. Where 109 
appropriate, costs were inflated or deflated to 2014-15 prices using the NHS Hospital 110 
and Community Health Services Pay and Prices Index [10]. 111 
 112 
Cost of distal tibia fixation 113 
The initial surgical costs (intervention costs) were based on the initial hospital stay 114 
and associated operative costs as reported in table I. Unit costs were estimated 115 
using NHS reference costs, and the Healthcare Resource Groups (HRG) tariff for 116 
‘major knee procedures for trauma’[11]. Based on this tariff, distal tibia fixation costs 117 
the NHS £5315.47 if a patient stays in hospital an average of 5 days. Costs of the 118 
initial surgery were derived for each patient using the mean length of stay reported in 119 
the patient records. An excess bed day value of £327.00 was used to adjust the 120 
surgery costs of patients who stayed in hospital longer than 5 days. We assumed 121 
that treatment costs were disproportionately weighted towards the first 3 days of 122 
each initial hospital admission. Thus, the cost to the NHS of a patient who stayed in 123 
hospital for 3 days was calculated as £5315.47 – (2x£327), i.e. the 5-day tariff minus 124 
the bed day cost of £327 per each day not spent in hospital. The numbers of 125 
implants used during the surgery were derived from patient records. Unit costs for 126 
these implants were provided by the University Hospitals of Coventry and 127 
Warwickshire NHS trust finance department.  128 
 129 
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Broader resource use  130 
Broader resource use over the 12-month follow-up period was captured via follow-up 131 
postal questionnaires, which were completed at 3-, 6- and 12-months post-132 
randomisation. For the 3-month data, the recall period was since hospital discharge 133 
whilst at other time points, it was since completion of the previous questionnaire. The 134 
questionnaires captured the number, duration and type of hospital re-admissions 135 
following initial surgery, number and type of hospital outpatient visits and diagnostic 136 
tests, number and type of community health and social services, and the use of 137 
medications, aids and adaptations. Furthermore, respondents provided information 138 
on direct non-medical costs (including travel expenses) incurred by themselves and 139 
their caregivers, and reported number of days off work and gross loss of earnings, 140 
attributable to their health state or contacts with care providers. Resource use values 141 
were converted into costs by applying unit costs obtained from national databases 142 
such as the Department of Health’s National Schedule of Reference Costs [11, 12], the 143 
PSSRU Unit Costs of Health and Social Care compendium,[13-15], the Annual survey 144 
of Hours and Earnings [16], the NHS supply chain catalogue [17] and the British 145 
National Formulary (BNF) [18] . Table II summarises the unit cost values and data 146 
sources for broader resource inputs.  147 
 148 
Measurement and valuation of health outcomes 149 
In line with the NICE reference case, the primary health outcome for the economic 150 
evaluation was the quality-adjusted-life-year (QALY) [8], which combines impacts on 151 
both health-related quality of life (HRQoL) and length of life [19]. HRQoLwas 152 
assessed using the EQ-5D-3L questionnaire (EQ-5D for brevity) [20] at baseline and 153 
at 3, 6 and 12 months post-randomisation. The EQ-5D comprises five dimensions: 154 
‘mobility’, ‘self-care’, ‘usual activities’, ‘pain/discomfort’ and ‘anxiety/depression. 155 
Responses in each dimension have 3 levels: (1) no problems; (2) moderate 156 
problems; and (3) extreme problems. EQ-5D health states can be converted into a 157 
single summary index by applying a utility algorithm, which attaches values to each 158 
permutation of responses to the EQ-5D descriptive system. We applied utility values 159 
for EQ-5D health states elicited from a general population sample in the UK using 160 
the time-trade-off method [21]. Utility values generated through this method range 161 
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from -0.59 to 1.0; where 0 represents death, 1.0 represents full health and values 162 
below 0 indicate health states worse than death. QALY values for each patient were 163 
estimated by calculating the area under the baseline-adjusted utility curve, and were 164 
calculated using linear interpolation between baseline and follow-up utility scores. 165 
 166 
Missing data  167 
For the baseline analysis, multiple imputation under chained equations (MICE) [22] 168 
was used to model missingness for those cases where resource use or HRQoL data 169 
were unavailable, based on the tested assumption that data were missing at random. 170 
Regression models were used to impute unobserved costs and QALYs at each time 171 
point, and by treatment allocation, using age and gender as explanatory variables. 172 
Costs and EQ-5D utility scores at each time point contributed as both explanatory 173 
and imputed variables. The imputation was run 50 times following the rule of thumb 174 
that the number of imputations should be similar to the percentage of incomplete 175 
cases[22]. Fifty datasets were generated using predictive mean matching. Each 176 
imputed data set produced was independently analysed with bivariate regressions 177 
using a seemingly unrelated regression model to estimate the costs and QALYs in 178 
each treatment group over the 12-month trial horizon. Estimates from each imputed 179 
dataset were combined using Rubin’s rule to generate overall mean costs and QALY 180 
estimates and their standard errors [23].  181 
 182 
Analyses of resource use, costs and outcome data  183 
Resource use items were summarised by treatment group and follow-up period and 184 
differences between groups were analysed using t-tests for continuous variables and 185 
chi-squared tests for categorical variables. Means and standard errors (SEs) for 186 
values of each cost category were estimated by treatment allocation and follow-up 187 
period and statistical differences in mean costs by treatment allocation were 188 
assessed using t-tests. Mean total costs by treatment allocation and follow-up period 189 
were also estimated. Statistically significant differences in the mean total costs were 190 
assessed using non-parametric bootstrapping, based on 10,000 replications. 191 
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For each of the five dimensions of the EQ-5D, we calculated the proportion of 192 
patients reporting sub-optimal function (moderate or extreme problems) and 193 
assessed differences between groups using chi-squared tests.  194 
 195 
Cost-effectiveness analysis 196 
Cost-effectiveness results were expressed in terms of an incremental cost-197 
effectiveness ratio (ICER) and calculated by dividing the difference between 198 
treatments in mean total costs by the mean difference in total QALYs. The ICER 199 
represents the additional cost required to gain a QALY and in our case indicates 200 
whether investing additional resources on a particular type of fixation is cost-201 
effective. As a general rule, NICE considers interventions costing the NHS less than 202 
£20,000 per QALY gained cost-effective [24]. To determine the level of sampling 203 
uncertainty around the ICER, we conducted non-parametric bootstrapping, 204 
generating 50,000 estimates of incremental costs and benefits [25]. The bootstrap 205 
replicates from the non-parametric bootstrapping were used to populate cost-206 
effectiveness scatterplots. We calculated the net-monetary benefit (NMB) of using 207 
nail fixation versus locking plate fixation across three cost-effectiveness thresholds: 208 
£15,000 per QALY, £20,000 per QALY and £30,000 per QALY [26]. A positive 209 
incremental NMB indicates that the intervention is cost-effective compared with the 210 
alternative at the given cost-effectiveness threshold. Furthermore, cost-effectiveness 211 
acceptability curves (CEACs) were generated based on the proportion of bootstrap 212 
replicates with positive incremental net benefits. The CEACs indicate the probability 213 
that nail fixation is cost-effective relative to locking plate fixation across a range of 214 
cost-effectiveness thresholds.  215 
 216 
Sensitivity and sub-group analyses 217 
Several sensitivity analyses were undertaken to assess the impact of parameters 218 
with a degree of uncertainty on cost-effectiveness outcomes. These included: 1) 219 
restricting the analyses to complete cases (i.e. those with complete cost and 220 
outcome data over the 12-month follow-up period); 2) adopting a wider societal 221 
perspective that included private costs incurred by trial participants and their families, 222 
productivity losses and loss of earnings due to work absences; 3) estimating the 223 
9 
 
 
cost-effectiveness under a per-treatment analysis; and 4) additionally adjusting the 224 
baseline analysis for pre-injury HRQoL, which was assessed using the EQ-5D at 225 
baseline. 226 
Sub-group analyses were also conducted for the main cost-effectiveness results to 227 
explore heterogeneity in the trial population. These were conducted by: (i) age group 228 
(<50 and ≥50 years) and (ii) gender (male, female).  229 
 230 
Longer-term economic modelling 231 
The study protocol allowed for decision-analytic modelling to estimate the cost-232 
effectiveness of intramedullary nail fixation over a longer-term time horizon, drawing 233 
on best available secondary data sources, supplemented where necessary by expert 234 
opinion. Use of a lifelong time horizon may be warranted in cost-effectiveness 235 
analysis when there is reason to expect differences in long-term costs and QALYs. 236 
Factors that could affect either include differences in life expectancy, HRQoL, and 237 
rehospitalisation or reoperation rates.  238 
 239 
Beyond the 12-month follow-up period assessed in this study, rehospitalisation and 240 
reoperation are possible due to excess complications [3]. We conducted a preliminary 241 
analysis of the extended follow-up data for this trial to determine whether differences 242 
in HRQoL outcomes, metalwork removal and in rates of complications persisted at 243 
24 months. Furthermore, we systematically searched external studies that compared 244 
plate and nail fixation for evidence on clinically important differences beyond 12-245 
months post-surgery. Though we did not find good quality external evidence, 246 
analysis of the composite of available data indicates that, beyond 12 months, rates 247 
of deep infection and wound healing are similar [2, 3, 27]. According to a recent 248 
analysis of 358 patients in Belgium, total length of stay in hospital (due to initial 249 
surgery and reoperations) and rate of deep infections are the major cost-drivers of 250 
tibial shaft fractures [28]. The combined evidence thus indicated that clinical and 251 
economic differences between nail and plate fixation are likely concentrated in the 252 
first year following surgery. This informed our decision not to undertake longer-term 253 
economic modelling.  254 
 255 
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 256 
 257 
Results 258 
 259 
Between April 2013 and February 2016, 321 patients were recruited and randomised 260 
(nail fixation = 161; locking plate = 160). Three patients did not complete the 261 
baseline questionnaires. A total of 276 patients completed the 3-month questionnaire 262 
whilst 284 and 258 patients returned questionnaires at the 6- and 12-month follow-up 263 
time points, respectively. Overall, the follow-up rate was greater than 80% at all time-264 
points. The trial results based on the primary clinical outcome measure, as well as 265 
details on time to union, postoperative complications at the 6-week assessment, and 266 
the number and type of further surgical interventions associated with the fracture in 267 
each group within 12 months of initial surgery, are presented elsewhere [7]. Table III 268 
shows the volume of missing health economic data by treatment allocation and 269 
follow-up time point. The missing data pattern was non-monotonic since several 270 
individuals with missing data at one follow-up time point completed subsequent 271 
questionnaires. 272 
 273 
Resource use  274 
Resource use was generally higher for participants allocated to the locking plate 275 
group compared to those allocated to nail group, but this was not always statistically 276 
significant (Table A1; Appendix). The exceptions, which showed statistically 277 
significant differences, were the mean total inpatient stay between 3-6 months (0 278 
(nail) vs. 0.11 (locking plate) days), and mean total outpatient care contacts between 279 
3-6 months (3.64 vs. 4.78 contacts). The differences in outpatient care appear to be 280 
driven by increased physiotherapy contacts in the locking plate group (1.84 vs. 2.53 281 
visits). 282 
 283 
Costs  284 
The mean intervention costs from admission until discharge were £5460 for nail 285 
fixation compared to £5600 for locking plate fixation; the mean difference of £140 286 
(CI: -684.24 to 262.61; P=0.19) (table IV) The mean length of the initial hospital stay 287 
was 3.87 days (SE 0.34) for nail fixation vs. 3.85 days (SE 0.33) for locking plate 288 
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fixation. The mean total NHS and PSS cost throughout the first 6 months post-289 
randomisation was £5876 for nail fixation and £6814 for locking plate fixation; the 290 
mean cost difference of £939 was statistically significant at the 5% significance level 291 
(P=0.04). The mean total NHS and PSS cost for the entire 12-month follow-up period 292 
was £6107 for nail fixation and £7102 for locking plate fixation; the mean cost 293 
difference of £995 was statistically significant at the 10% significance level (P=0.05). 294 
Productivity losses to employers through sickness absences appeared higher in the 295 
locking plate arm, and the difference for the entire follow-up period was statistically 296 
significant at the 10% level. Overall societal costs, for the entire follow-up period, 297 
were on average £3396 higher in the locking plate group; this cost difference was 298 
statistically significant at the 5% level  (P=0.01) (table V)  299 
 300 
Health-related quality of life outcomes 301 
Table A2 (Appendix) summarises the number and proportion of reported problems 302 
for each level for each dimension of the EQ-5D. The proportion of trial participants 303 
reporting suboptimal function is also indicated for each dimension and the difference 304 
between the two treatment arms shown using p-values. With the exception of 305 
mobility at 3 months (81% nail vs. 89% locking plate), which was statistically 306 
significant at the 10% significance level, there were no significant differences in the 307 
proportions of individuals reporting sub-optimal function within dimensions between 308 
the two arms at each time point.  309 
 310 
The EQ-5D utility scores pre-injury, post-injury (baseline) and at 3-, 6- and 12 311 
months post-randomisation are shown in table VI and figure 1. Both groups showed 312 
improvement in HRQoL from baseline to the last follow-up point. The most notable 313 
difference was observed at 6 months post-randomisation with a higher utility value 314 
observed for the nail fixation group (P=0.03).  315 
 316 
The mean total QALYs (imputed) over the 12 months for IM nail and locking plate 317 
fixation were 0.55 and 0.54 respectively, but the difference was not statistically 318 
significant (0.01 QALYs, 95% CI: -0.03 to 0.06; P=0.56).  319 
 320 
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Cost-effectiveness analysis 321 
The baseline economic evaluation, using imputed attributable costs and QALYs and 322 
covariate adjustment, indicated that intramedullary nail fixation was associated with 323 
significantly lower mean NHS and PSS costs (-£970 (95% CI: -1685 to -256) and a 324 
non-statistically significant increase in QALYs (0.01 QALYs, 95% CI: -0.03 to 0.06) 325 
over the entire 12-month follow-up period (table VII). Uncertainty surrounding the 326 
ICER estimates are represented graphically in the cost-effectiveness plane (figure 327 
2), which shows that most simulated ICER values fall in the south-east quadrant, 328 
indicating that nail fixation is on average less costly and more effective (produced 329 
more QALYs). The probability of cost-effectiveness given the uncertainty 330 
surrounding the mean ICER value is visually displayed in the CEAC. The probability 331 
that nail fixation is cost-effective ranged between 94-98% across cost-effectiveness 332 
thresholds of £15,000-£30,000 per QALY (table VII; figure 3). The net-monetary 333 
benefit for IM nail, for the base case, was positive (incremental NMB values>£1200). 334 
 335 
Sensitivity and sub-group analyses 336 
Most of the sensitivity analyses undertaken (complete case, societal perspective, 337 
and imputed attributable costs and QALYs additionally controlled for pre-injury utility) 338 
supported the base case finding (table VII). However, the per-treatment analysis 339 
showed a slightly different pattern for QALY outcomes. The results for that analysis 340 
indicated that participants in the nail fixation arm, on average, experienced slightly 341 
worse QALY outcomes (-0.01 QALYs (95% CI -0.06 to 0.04)). However, the result 342 
was not statistically significant. Moreover, the cost difference remained in the same 343 
direction (-875 (95% CI -1725 to -26)) as that for the base case analysis. The results 344 
of the sub-group analyses indicate that in the sample of patients below the age of 50, 345 
nail fixation was the dominant intervention; it lowered costs and moderately 346 
increased QALYs on average (table VII). In patients over the age of 50 years, nail 347 
fixation was associated with lower costs (-£821) and lower benefits (-0.022 QALYs), 348 
on average, compared to locking plate fixation. However, the 95% confidence 349 
intervals for both the incremental cost (95% CI -2760 to 1110) and QALY (95% CI -350 
0.09 to 0.05) estimates suggest considerable uncertainty surrounding the effects of 351 
intramedullary nail fixation for this older group of patients.  352 
 353 
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 354 
Discussion and Conclusion 355 
This study shows that nail fixation ‘dominates’ locking plate fixation in health 356 
economic terms. This conclusion is driven by the finding that there was a modest 357 
QALY gain in the nail group over the 12-month time horizon of the trial and costs 358 
were significantly lower in the nail group. In addition, there was a high probability that 359 
nail fixation is cost-effective across cost-effectiveness thresholds recommended by 360 
decision-makers, a finding that remained robust to most sensitivity and sub-group 361 
analyses. The main exception to this pattern of results was the sub-group of patients 362 
above 50 years in whom nail fixation was associated with a reduction in costs, but 363 
also marginally lower QALYs, although there was substantial uncertainty around the 364 
estimates. A retrospective review of forty-two patients (>50 years old) found that 365 
older patients sustaining tibial shaft fractures treated with intramedullary nailing take 366 
longer to heal, and require more procedures to achieve union [29].  This external 367 
evidence suggests that other factors may need to be taken into account when 368 
deciding the optimal treatment approach for distal tibia fractures in the elderly.  369 
 370 
To our knowledge, this is the first trial-based economic evaluation to compare the 371 
cost-effectiveness of these two surgical procedures for the treatment of distal tibia 372 
fractures. Previous studies have compared two types of intramedullary nails (reamed 373 
vs. unreamed) in treating closed and open tibia fractures; however, they did not 374 
compare intramedullary nails to other interventions [5]. Busse and colleagues 375 
reported costs associated with treatment of low-energy tibial fractures with either 376 
casting, casting with therapeutic ultrasound, or intramedullary nailing (with and 377 
without reaming) by use of a decision tree model [30]. The results of that analysis 378 
indicated that intramedullary nailing was the treatment of choice for closed and open 379 
grade I tibial shaft fractures; however, impact on HRQoL was not assessed. Kao et 380 
al conducted a cost-effectiveness analysis comparing conventional buttress or 381 
dynamic compression plates and locking plates for treating displaced distal tibial 382 
fractures, but did not conduct a comparative assessment with intramedullary nails [6]. 383 
The same interventions have been compared in different clinical contexts, for 384 
example, for the treatment of midshaft clavicle fractures [31, 32]; however the cost-385 
effectiveness evidence in those contexts remains limited [33].  386 
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 387 
Strengths of the current economic evaluation include data collected from a 388 
prospective randomised trial with frequent assessments over a 12-month follow-up 389 
period and minimal loss to follow-up. This enabled a trial-based economic evaluation 390 
that was rigorous, with effectiveness and cost measures (including indirect patient-391 
reported costs) collected prospectively, and the direct measurement of utility scores 392 
from our study participants to calculate QALYs [34]. Furthermore, the economic 393 
evaluation was conducted according to nationally agreed design and reporting 394 
guidelines [35].  395 
 396 
Limitations of this trial-based economic analysis include that long-term cost-397 
effectiveness beyond the 12-month follow-up period was not assessed. However, 398 
preliminary analysis of the HRQoL outcomes of the trial participants using extended 399 
follow-up data for this trial indicates that EQ-5D utility scores for the nail fixation and 400 
locking plate groups remain similar at 24 months post-randomisation (extended 401 
follow-up data will be reported in due course). In addition, by 12 months, rates of 402 
metalwork removal, revision fixations and other secondary operative procedures 403 
were similar between the locking plate and nail fixation groups [7].The indication, 404 
therefore, is that the benefits of nail fixation are very likely to be concentrated in the 405 
first year that follows the treatment of displaced, extra-articular fractures of the distal 406 
tibia. Furthermore, our systematic search for external studies that compared plate 407 
and nail fixation did not find any good quality evidence on differences in functional 408 
outcomes and HRQoL beyond 12 months post-surgery. The available studies were 409 
either based on short follow-up periods,[36] small sample sizes,[2] non-randomised 410 
studies that relied on retrospective reviews or case series which tend to suffer from 411 
selection biases, [2, 37] or a combination of these factors. A second potential limitation 412 
is that we used NHS tariffs to estimate total cost of the surgical treatment, which 413 
some have argued do not fully capture the cost of orthopaedic procedures and may 414 
not take into account varying operating theatre times [38, 39]. However, in our case, it 415 
is unlikely that a different costing approach would have shifted results in favour of the 416 
locking plate as the mean operating theatre times were the same (124mins) for both 417 
procedures and the cost of implants represented a relatively minor component of 418 
total costs. 419 
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 420 
In conclusion, our study provides a comprehensive assessment of the cost-421 
effectiveness of two commonly undertaken treatments for distal tibia fractures with 422 
obvious implications for the orthopaedic community. Notwithstanding the limitations 423 
of within-trial analyses, this study provides robust evidence that over the first year 424 
that follows surgery, nail fixation is a cost saving intervention without detriment to 425 
health-related quality of life outcomes. Given these results, there is economic 426 
justification for recommending nail over locking plate fixation for the management of 427 
extra-articular distal tibia fractures.  428 
  429 
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 550 
Table I: Unit costs (£, 2014-15 prices) associated with initial operative procedures and 551 
initial hospital stay for intramedullary nail and locking plate fixation 552 
Item  Unit Cost  Source 
Surgery Costs1    
Average surgery cost of distal tibia 
fracture fixation (based on mean length 
of stay of 5 days2) 
£ 5,315.47 National schedules of Reference 
Costs year 2014-15 - 'Major Knee 
Procedures for Trauma, 19 years and 
over, with CC Score 0'-HT23D[11] 
Cost per excess bed day £ 327.00 National schedules of Reference 
Costs year 2014-15 - 'Major Knee 
Procedures for Trauma, 19 years and 
over, with CC Score 0'-HT23D[11] 
Implants: Intramedullary nail fixation   
Guide wire 3.2x300 £43.11  UHCW3 
Reaming rod 2.5x1000  £63.47  UHCW 
Distal bolts £45.88  UHCW 
End cap  £37.93  UHCW 
Blocking Screw £29.80  UHCW 
Nail £265.53  UHCW 
 553 
  554 
                                                          
1HRG Code for distal tibia fracture fixation is similar for both intramedullary and locking plate fixation   
2 Surgery cost from NHS Reference Costs is based on assumed mean length of stay of 5 days for this category of patients; 
adjustments were made for all patients who stayed in hospital for a period less than 5 days; detailed methodology explained in-
text. 
3 UHCW denotes University Hospitals Coventry and Warwick NHS Trust Finance Department 
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Table II: Summary of unit cost values (£, 2014-15 prices) and data sources 555 
Resource item Unit cost Unit of 
analysis 
Source of unit cost 
Subsequent inpatient care 
 
    
Orthopaedics (your leg) 
 
    
Cost per average LoS4 of 1 day £1,780.34 per procedure NHS Reference Costs 2014-2015, 
'Minor Knee Procedures for Non-
Trauma, 19 years and over' - 
HN25A[11] 
Day Case £1,349.10 
per procedure 
 
    
Orthopaedics (any other bones) 
 
    
Cost per average LoS of 4 days £2,648.56 per procedure  NHS Reference Costs 2014-2015, 
'Other Muscle, Tendon, Fascia or 
Ligament Procedures' - HN93Z[11] 
Day Case £965.19 
  
Adjustment per day ± avg. LoS 
(excess bed days) 
£278.52 per day NHS Reference Costs 2014-2015, 
'Other Muscle, Tendon, Fascia or 
Ligament Procedures' - HN93Z[11] 
    
Other Inpatient 
 
    
Rehabilitation Unit  £335.00 per session NHS Reference Costs 2013-2014, 
'Rehabilitation for other trauma', 
V636Z[12] 
 
   
Outpatient Care 
 
    
Orthopaedics  £112.50 per session Reference Costs 2014-2015 [11] 
Blood tests/ Phlebotomy £3.00 per test Reference Costs 2014-2015 [11] 
X-rays £30.23 per test Reference Costs 2014-2015[11] 
MRI scan £146.00 per test Reference Costs 2014-2015[11] 
CT scan £111.00 per test Reference Costs 2014-2015[11] 
Hospital Physiotherapist (NHS) £38.00 per session PSSRU 2015 pg.217 [13] 
Physiotherapist (private) £70.00 per hour http://www.thephysiocentre.co.uk/h
ow_much/ 
Emergency department 
(orthopaedics & trauma) 
£112.50 per session Reference Costs 2014-2015 [11] 
Emergency department other £140.59 
 
Reference Costs 2014-2015[11] 
    
Primary and community care  
 
    
General Practitioner surgery 
consultation 
£225.00 per hour PSSRU 2015 pg. 178[13] 
General Practitioner home visit £5.20 per home visit 
minute 
PSSRU 2010 pg. 167[15] 
General Practitioner phone call £27.00 per telephone 
consultation 
lasting 7.1 
minutes 
PSSRU 2015 pg. 178[13] 
Practice nurse  £56.00 per hour of 
face-to-face 
contact 
PSSRU 2015 pg. 174[13] 
                                                          
4 LoS denotes length of stay 
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Resource item Unit cost Unit of 
analysis 
Source of unit cost 
District nurse £67.00 per hour of 
patient related 
work 
PSSRU 2015 pg. 169[13] 
Community Physiotherapist £36.00 per hour of 
consultation 
PSSRU 2015 pg. 179[13] 
Occupational therapist £44.00 per hour PSSRU 2015 pg. 191[13] 
    
Personal Social Services 
 
    
Meals on wheels (frozen, daily) £46.00 
per weekly 
meal PSSRU 2014 pg. 127[14]  
Meals on wheels (hot, daily) £44.00 
per weekly 
meal PSSRU 2014 pg. 127[14] 
Laundry services £4.55 per load 
North Yorkshire Country Council  
http://www.northyorks.gov.uk/article
/23988/Paying-for-social-care-
services-in-the-community 
Social worker contacts £42.00 per hour PSSRU 2015 pg. 95[13] 
Care worker contacts including help 
at home £24.00 per hour PSSRU 2015 pg. 192[13] 
    
Aids and Adaptations     
    
Crutches £5.06 per unit NHS supplies catalogue 2015/16[17] 
Stick £3.94 per unit NHS supplies catalogue 2015/16[17] 
Zimmer frame £35.99 per unit NHS supplies catalogue 2015/16[17] 
Grab Rail £1.61 per unit NHS supplies catalogue 2015/16[17] 
Dressing aids £1.66 per unit NHS supplies catalogue 2015/16[17] 
Long handle shoe horn £1.66 per unit NHS supplies catalogue 2015/16[17] 
    
Productivity losses       
Median wage rate (full-time males) £567.00 per week  
Annual survey of hours and 
earnings (ASHE, 2015)[16] 
Median wage rate (full-time females) £471.00 per week  ASHE, 2015[16] 
Median wage rate (part-time males) £156.00 per week  ASHE, 2015[16] 
Median wage rate (part-time 
females)  £171.00 per week ASHE, 2015[16] 
Median earnings (self-employed) £10800.00 per year 
https://www.gov.uk/government/upl
oads/system/uploads/attachment_d
ata/file/500317/self-employed-
income.pdf 
 556 
  557 
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Table III Number and proportion of individuals with missing health economic data by 558 
treatment allocation 559 
 560 
Variable Description Missing values: N (%) 
  
Nail (N=158) Locking 
Plate 
(N=160) 
Total 
eq5db EQ-5D index score pre-injury 1 (1%) 1 (1%) 2 (1%) 
eq5d0 EQ-5D index score post-injury 2 (1%) 3 (2%) 5 (2%) 
eq5d1 EQ-5D at 3 months 23 (15%) 19 (12%) 42 
(13%) 
eq5d2 EQ-5D at 6 months 16 (10%) 18 (11%) 34 
(11%) 
eq5d3 EQ-5D at 12 months 43 (27%) 42 (26%) 85 
(27%) 
c0 Operative costs (surgery cost 
including initial hospital stay + 
implants)  
0 (0%) 0 (0%) 0 (0%) 
c1 Total resource use baseline - 3 
months 
54 (34%) 54 (34%) 108 
(34%) 
c2 Total resource use between 3- 6 
months 
30 (19%) 31 (19%) 61 
(19%) 
c3 Total resource use between 6- 
12 months  
60 (38%) 58 (36%) 118 
(37%) 
c4 Total resource use between 0- 6 
months  
67 (42%) 62 (39%) 129 
(41%) 
c5 Total resource use between 0- 
12 months  
88 (56%) 82 (51%) 170 
(54%) 
 561 
  562 
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Table IV NHS and personal social service costs for cases with complete data by trial 563 
allocation, study period and cost category (£, 2014-15 prices) 564 
Cost category by 
period 
Nail 
Mean (SE) Cost 
Locking Plate 
Mean (SE) Cost 
Mean 
Difference 
P Value a Bootstrap 95% CI b 
 
0-6months (n = 189 total; n= 91 IM; N=98 LP) 
Initial operation cost 5460.04 (137.92) 5600.11 (137.92) -140.07 0.19 (-684.24 to 262.61) 
Subsequent inpatient 
care  
40.73 (29.35) 313.14 (187.55) -272.41 0.08 (-648.97 to 104.13) 
Outpatient care 218.66 (11.46) 249.01 (19.49) -30.35 0.09 (-75.00 to 14.31) 
Community care  106.91 (28.42) 601.69 (371.42) -494.78 0.10 (-1233.98 to 
244.42) 
Medications 37.73 (10.18) 38.83 (14.28) -1.11 0.47 (-35.73 to 33.52) 
Personal social services 0.52 (0.52) 0.98 (0.59) -0.46 0.28 (-2.02 to 1.10) 
Aids and adaptations 10.97 (2.30) 10.45 (1.61) 0.52 0.58 (-5.02 to 6.06) 
Total costs throughout 
first 6 months 
5875.56 (124.85) 6814.22 (425.71) -938.66 0.04* (-1795.46 to -83.62) 
 
0-12months (n = 160 total; n= 70 IM; N=78 LP) 
Initial operation costs 5428.47 (112.00) 5528.72 (114.25) -100.26 0.53 (-671.23 to 298.66) 
Subsequent inpatient 
care  
234.91 (92.68) 596.25(237.18) -361.34 0.16 (-848.35 to 211.12) 
Outpatient care 268.94 (16.90) 299.14 (26.25) -30.20 0.34 (-100.29 to 27.88) 
Community care  107.09 (23.30) 588.22 (410.64) -481.13 0.25 (-1401.81 to 
361.51) 
Medications 58.14 (19.60) 78.45(35.95) -20.31 0.62 (-111.91 to 62.76) 
Personal social services 0.32 (0.32) 0.91 (0.64) -0.59 0.40 (-2.16 to 0.88) 
Aids and adaptations 9.45 (2.08) 10.77 (1.89) -1.28 0.65 (-7.90 to 2.03) 
Total costs throughout 
first 12 months 
6107.32 (158.56) 7102.46 (485.18) -995.14 0.05 (-2069.63 to -74.93) 
a P value calculated using student t-test, 2 tail unequal variance 
b Non-parametric bootstrap estimation using 1,000 replications  
 565 
 566 
  567 
25 
 
 
Table V: Societal costs related to distal fracture fixation for cases with complete data 568 
by treatment arm (£, 2014-15) 569 
Cost category 
by period  
Nail 
Mean (SE) Cost 
Locking Plate 
Mean (SE) Cost 
Mean 
Difference 
P Value a 
Follow up-period: 0 – 6 month 
NHS and PSS 
costs  
5875.56 (124.85) 6814.22 (425.71) -938.66 0.04 
Private costs  16.36 (8.02) 12.46 (3.74) 3.90 0.65 
Cost of lost 
productivity  
3901.13 (759.48) 5351.80 (814.56) -1450.67 0.20 
Societal costs  9793.05 (761.66) 12178.48 (1003.33) -2385.43 0.07 
     
Follow-up period: 0 – 12 months  
NHS resource 
use costs  
6107.32 (158.56) 7102.46 (485.18) -995.14 0.05 
Private costs  49.52 (35.72) 24.65 (7.80) 24.87 0.48 
Cost of lost 
productivity  
3333.28 (649.45) 5758.62 (1032) -2425.34 0.05 
     
Societal costs  9490.12 (658.07) 12885.73 (1174.33) -3395.61 0.01 
 
a P value calculated using student t-test, 2 tail unequal variance  
 570 
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Table VI Mean EQ-5D index scores at the baseline and follow-ups: nail vs. locking 572 
plate for distal tibia fixation 573 
 Intramedullary Nail Locking Plate Difference (95%CI)  
Time 
point 
Mean (SD) n Mean (SD) n Raw  Adjusted* p-value 
Post-injury -0.003 
(0.334) 
158 -0.024 (0.311) 156 -0.021 -0.030  
(-0.09 to 0.03) 
0.331 
3 months 0.546 (0.273) 134 0.499 (0.302) 142 -0.047 -0.058 
 (-0.12 to 0.00) 
0.067 
6 months 0.670 (0.265) 143 0.622 (0.275) 141 -0.048 -0.064  
(-0.12 to -0.01) 
0.029 
12 months 0.722 (0.278) 128  0.731 (0.246) 130 0.009 -0.018 
 (-0.07 to 0.05) 
0.525 
*Mixed effects regression model based on intention to treat analysis approach. Fixed effects were 
allocated treatment group, age group, baseline pre-injury score and gender, and recruiting site 
was a random effect. 
 574 
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Table VII: Cost-effectiveness, cost/QALY (£, 2015): intramedullary nail fixation compared to locking plate fixation 
 Incremental 
cost (95% CI) 
Incremental 
QALYs (95% CI) 
ICER * Probability of cost-
effectiveness 
 
Net monetary benefits 
 
 
    P1 P2 P3 NMB1 (95% CI) NMB2 (95% CI) NMB3(95% CI) 
Base Case 
Imputed attributable costs 
and QALYs, covariate 
adjusted 
-970 
(-1685 to -256) 
0.01 
(-0.03 to 0.06) 
Dominant 0.98 0.97 0.94 1204 
(43 to 2465) 
1273 
(-82 to 2689) 
1410 
(-385 to 3190) 
 
Sensitivity analyses 
Complete case attributable 
costs and QALYs, 
covariate adjusted 
-1791 
(-3986 to -225) 
0.04 
(-0.02 to 0.09) 
Dominant 0.99 0.98 0.98 1429 
(146 to 2818) 
1558 
(118 to 3069) 
1818 
(36 to 3626) 
Societal perspective  -2230 
(-4626 to 167) 
0.014 
(-0.03 to 0.06) 
Dominant 0.97 0.97 0.96 2423 
(-26 to 5173) 
2493 
(-93 to 5337) 
2626 
(-270 to 5706) 
Per treatment analysis – 
imputed attributable costs 
and QALYs, covariate 
adjusted 
-875 
(-1725 to -26) 
-0.01 
(-0.06 to 0.04) 
172857 
(south-west 
quadrant) 
0.92 0.88 0.81 923 
(-347 to 2353) 
909  
(-570 to 2508) 
872 
(-1032 to 2861) 
Imputed attributable costs 
and QALYs, additionally 
controlling for pre-injury 
utility 
-1188 (-2266 to 
-110) 
0.02 
(-0.02 to 0.06) 
Dominant 
 
0.99 0.99 0.98 1518 
(212 to 2940) 
1633 
(180 to 3194) 
1862 
(66 to 3738) 
          
Subgroup analyses 
Base Case: age <50 -1468 
(-3547 to -291) 
0.08 
(0 to 0.17) 
Dominant 0.99 0.98 0.98 1730 
(207 to 3320) 
1953 
(166 to 3804) 
2402 
(55 to 4830) 
Base case: age ≥50 -821 
(-2760 to 1110) 
-0.022 
(-0.09 to 0.05) 
60000 
(south-west 
quadrant) 
0.71 0.67 0.62 709 
(-1960 to 3480) 
630  
(-2320 to 3610) 
473 
(-3065 to 3930) 
Base Case: males -1651  
(-5042 to -682) 
0.05 
(-0.07 to 0.17) 
Dominant 0.71 0.68 0.62 745 
(-1945 to 3612) 
670  
(-2305 to 3741) 
520 
(-3043 to 4075) 
Base Case: females -1193 
(-5243 to 102) 
0.02 
(-0.05 to 0.10) 
Dominant 0.71 0.68 0.62  746 
(-1950 to 3643) 
673 
(-2307 to 3781) 
 529 
(-3049 to 4157) 
*ICER: Incremental cost-effectiveness ratio; dominance indicates average costs were less and average benefit greater for intramedullary nail vs. locking plate fixation 
P1, P2, P3: probability cost-effective if willing to pay £15,000/QALY, £20,000/QALY or £30,000/QALY, respectively  
NMB1, NMB2,NMB3: net monetary benefit if willing to pay £15,000/QALY, £20,000/QALY or £30,000/QALY, respectively  
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